comparemela.com

Latest Breaking News On - Nyse taro - Page 7 : comparemela.com

Teledyne Technologies (NYSE:TDY) Issues Q2 2023 Earnings Guidance

Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Rating) shares gapped up before the market opened on Friday . The stock had previously closed at $25.29, but opened at $26.13. Taro Pharmaceutical Industries shares last traded at $26.13, with a volume of 276 shares trading hands. Wall Street Analyst Weigh In A number of equities research […]

Taro Pharmaceutical Industries (NYSE:TARO) Upgraded to Buy at StockNews com

Taro Pharmaceutical Industries (NYSE:TARO – Get Rating) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday. Separately, HC Wainwright cut their price objective on Taro Pharmaceutical Industries from $54.00 to $35.00 and set a “buy” rating on the […]

Taro Pharmaceutical Industries (NYSE:TARO) Sees Unusually-High Trading Volume

Shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Rating) saw unusually-strong trading volume on Monday . Approximately 9,107 shares changed hands during mid-day trading, a decline of 34% from the previous session’s volume of 13,853 shares.The stock last traded at $24.89 and had previously closed at $24.33. Wall Street Analyst Weigh In TARO has […]

Inspire Advisors LLC Purchases 913 Shares of Taro Pharmaceutical Industries Ltd (NYSE:TARO)

Inspire Advisors LLC raised its position in Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Rating) by 13.2% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,815 shares of the company’s stock after acquiring an additional 913 shares during the quarter. Inspire Advisors LLC’s holdings […]

Taro Pharmaceutical Industries (NYSE:TARO) Downgraded by StockNews com

StockNews.com lowered shares of Taro Pharmaceutical Industries (NYSE:TARO – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Saturday. Separately, HC Wainwright lowered their price objective on Taro Pharmaceutical Industries from $54.00 to $35.00 and set a buy rating for the company in a research report […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.